The role of local IL6/JAK2/STAT3 signaling in high glucose–induced podocyte hypertrophy
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in Kidney Research and Clinical Practice
- Vol. 35 (4) , 212-218
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (HI10C1268)
This publication has 31 references indexed in Scilit:
- Early Activation of Rat Skeletal Muscle IL-6/STAT1/STAT3 Dependent Gene Expression in Resistance Exercise Linked to HypertrophyPLOS ONE, 2013
- Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) Attenuates Interleukin-6 (IL-6)-induced Collagen Synthesis and Resultant Hypertrophy in Rat HeartJournal of Biological Chemistry, 2012
- Role of mTOR in podocyte function and diabetic nephropathy in humans and miceJournal of Clinical Investigation, 2011
- mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in miceJournal of Clinical Investigation, 2011
- Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathyKidney International, 2009
- Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic NephropathyDiabetes, 2009
- Association of Urinary Inflammatory Markers and Renal Decline in Microalbuminuric Type 1 DiabeticsJournal of the American Society of Nephrology, 2008
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle HypertrophyCell Metabolism, 2008
- Classic Interleukin-6 Receptor Signaling and Interleukin-6 trans-Signaling Differentially Control Angiotensin II-Dependent Hypertension, Cardiac Signal Transducer and Activator of Transcription-3 Activation, and Vascular Hypertrophy in VivoThe American Journal of Pathology, 2007
- p27Kip1 knockout mice are protected from diabetic nephropathy: Evidence for p27Kip1 haplotype insufficiencyKidney International, 2005